Page last updated: 2024-12-08

3-dehydroquinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-dehydroquinic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3-dehydroquinic acid : A 4-oxo monocarboxylic acid derived from quinic acid by oxidation of the hydroxy group at position 3 to the corresponding keto group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439351
CHEBI ID17947
SCHEMBL ID162709
MeSH IDM0450169

Synonyms (20)

Synonym
CHEBI:17947
rel-(1r,3r,4s)-1,3,4-trihydroxy-5-oxocyclohexanecarboxylic acid
1,3,4-trihydroxy-5-oxo-cyclohexanecarboxylic acid
3-dehydroquinic acid
10534-44-8
C00944
5-dehydroquinic acid
DB03868
(1r,3r,4s)-1,3,4-trihydroxy-5-oxocyclohexane-1-carboxylic acid
SCHEMBL162709
cyclohexan-1,4,5-triol-3-one-1-carboxylic acid
(1r,3r,4s)-1,3,4-trihydroxy-5-oxocyclohexanecarboxylic acid
WVMWZWGZRAXUBK-SYTVJDICSA-N
Q38224
1,3beta,4alpha-trihydroxy-5-oxocyclohexane-1beta-carboxylic acid
DTXSID50909453
cyclohexanecarboxylic acid, 1,3,4-trihydroxy-5-oxo-, (1r,3r,4s)-
q8hl497guu ,
unii-q8hl497guu
PD059452
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
4-hydroxy monocarboxylic acidA hydroxy monocarboxylic acid which has a hydroxy group located gamma to the carboxy group.
2-hydroxy monocarboxylic acid
4-oxo monocarboxylic acid
5-hydroxy monocarboxylic acid
secondary alpha-hydroxy ketoneAn alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing one hydrogen and one organyl group. Secondary alpha-hydroxy ketones are also known as acyloins, and are formally derived from reductive coupling of two carboxylic acid groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Chorismate Biosynthesis1017
Secondary Metabolites: Shikimate Pathway811
Shikimate Pathway (Chorismate Biosynthesis)716

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (21.05)18.7374
1990's0 (0.00)18.2507
2000's11 (57.89)29.6817
2010's4 (21.05)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.11 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.06 (4.65)
Search Engine Demand Index27.14 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (89.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]